BioClonetics Immunotherapeutics, Inc. — Form C/A (Regulation Crowdfunding)
BioClonetics Immunotherapeutics, Inc. of Heath, TX filed a Form C/A (Regulation Crowdfunding) with the SEC on 2017-09-01. Target raise $200K, up to $1.0M. Offered through Wefunder Portal LLC.
Offering
- Filed: 2017-09-01
- Form: C/A
- Accession: 0001670254-17-000251
- Target amount: $200K
- Maximum amount: $1.0M
- Security type: Other
- Securities offered: 200,000
- Price: $1.0000
- Deadline: 2017-10-08
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503
Issuer
- CIK: 0001701251
- Website: http://www.bioclonetics.com
- Legal status: Corporation
- Organized in: TX
- Incorporated: 2009-12-24
- Address: 1756 Bison Meadow Lane, Heath, TX, 75032
- Employees: 3
Financials (as filed)
- Total assets (most recent): $1K
- Cash (most recent): $1K
- Net income (most recent): $-81K
- Net income (prior): $-41K
People (13)
| Name | Role | Location |
|---|
| Gaurav Chandra | Chief Operating Officer | HEATH, TX |
| Gaurav Chandra | Vice President Research and Development | HEATH, TX |
| Joseph P. Cotropia, M.D. | President/CSO | HEATH, TX |
| Paul D. Fellegy | CFO | HEATH, TX |
| Paul D. Fellegy | Chief Financial Officer | HEATH, TX |
| Paul D. Fellegy | Treasurer | HEATH, TX |
| Seth Sheiner | Vice President Business and Scientific Development | HEATH, TX |
| Charles Cotropia | CEO | HEATH, TX |
| Charles Cotropia | CEO/President | HEATH, TX |
| Joseph Cotropia | CSO | HEATH, TX |
| Joseph Cotropia | Founder/CSO | HEATH, TX |
| Charles S. Cotropia | CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer | HEATH, TX |
| Charles S. Cotropia | Vice President | HEATH, TX |
Reg CF filing history (15)
More